GPS driving: a digital biomarker for preclinical Alzheimer disease

GPS driving: a digital biomarker for preclinical Alzheimer disease

Abstract Background Alzheimer disease (AD) is the most common cause of dementia. Preclinical AD is the period during which early AD brain changes are present but cognitive symptoms have not yet manifest. The presence of AD brain changes can be ascertained by molecular biomarkers obtained via imaging...

Full description

Bibliographic Details
Main Authors: Sayeh Bayat, Ganesh M. Babulal, Suzanne E. Schindler, Anne M. Fagan, John C. Morris, Alex Mihailidis, Catherine M. Roe
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Alzheimer’s Research & Therapy
Subjects:
Naturalistic driving
Preclinical Alzheimer disease
Global positioning system
Machine learning
Online Access:https://doi.org/10.1186/s13195-021-00852-1

Internet

https://doi.org/10.1186/s13195-021-00852-1

Similar Items